Hemokompatibilitet

Hemokompatibilitet refers to the ability of a material to be in contact with blood without eliciting an adverse reaction. This is a critical consideration in the design and use of medical devices and implants that come into direct or indirect contact with the circulatory system. When a foreign material interacts with blood, a complex cascade of biological events can be triggered. These can include activation of platelets, leading to thrombosis (blood clot formation), or activation of the immune system, resulting in inflammation and potential rejection of the device.

Achieving hemokompatibility often involves surface modification of materials. Techniques such as coating the surface with heparin, a natural anticoagulant, or designing surfaces that mimic the natural endothelial lining of blood vessels are employed. The chemical composition, surface topography, and electrical charge of a material can all influence its hemokompatibility. Materials that are deemed hemokompatible are essential for the safe and effective functioning of devices like artificial heart valves, stents, vascular grafts, and extracorporeal circuits used in dialysis or cardiopulmonary bypass. The development of hemokompatible materials is an ongoing area of research, aiming to minimize complications such as thromboembolism and immune responses, thereby improving patient outcomes.